Tempo Therapeutics, Inc.

CIK 1813688 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tempo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026D0001813688-26-000003
Mar 15, 2024D0001813688-24-000002
Aug 9, 2021D/A0001813688-21-000002
Jun 2, 2020D0001813688-20-000001